|
1
|
European Association For The Study Of The
Liver: EASL Clinical Practice Guidelines: Management of chronic
hepatitis B. J Hepatol. 50:227–242. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Chaiteerakij R, Komolmit P, Sa-nguanmoo P
and Poovorawan Y: Intrahepatic HBV DNA and covalently closed
circular DNA (cccDNA) levels in patients positive for anti-HBc and
negative for HBsAg. Southeast Asian J Trop Med Public Health.
41:867–875. 2010.PubMed/NCBI
|
|
3
|
Wong DK, Huang FY, Lai CL, Poon RT, Seto
WK, Fung J, Hung IF and Yuen MF: Occult hepatitis B infection and
HBV replicative activity in patients with cryptogenic cause of
hepatocellular carcinoma. Hepatology. 54:829–836. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chinese Society of Hepatology and Chinese
Society of Infectious Diseases, Chinese Medical Association: The
guideline of prevention and treatment for chronic hepatitis B (2010
version). Zhonghua Gan Zang Bing Za Zhi. 19:13–24. 2011.(In
Chinese). PubMed/NCBI
|
|
5
|
Seeger C and Mason WS: Molecular biology
of hepatitis B virus infection. Virology. 479(480): 672–686. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tian Z, Pan R, Chang Q, Si J, Xiao P and
Wu E: Cimicifuga foetida extract inhibits proliferation of
hepatocellular cells via induction of cell cycle arrest and
apoptosis. J Ethnopharmacol. 114:227–233. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yang RH: The effect of Cimicifuga
foetida on chronic hepatitis therapy used by Pro. Chi-Zhi
Zhang. Forum on Traditional Chinese Medicine. 27:122012.(In
Chinese).
|
|
8
|
Zheng TP, Sun AJ, Xue W, Wang YP, Jiang Y,
Zhang Y and Lang JH: Efficacy and safety of Cimicifuga
foetida extract on menopausal syndrome in Chinese women. Chin
Med J (Engl). 126:2034–2038. 2013.PubMed/NCBI
|
|
9
|
Bowden S, Jackson K, Littlejohn M and
Locarnini S: Quantification of HBV covalently closed circular DNA
from liver tissue by real-time PCR. Methods Mol Med. 95:41–50.
2004.PubMed/NCBI
|
|
10
|
Weinberger KM, Wiedenmann E, Böhm S and
Jilg W: Sensitive and accurate quantitation of hepatitis B virus
DNA using a kinetic fluorescence detection system (TaqMan PCR). J
Virol Methods. 85:75–82. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Marcellin P, Lau GK, Bonino F, Farci P,
Hadziyannis S, Jin R, Lu ZM, Piratvisuth T, Germanidis G, Yurdaydin
C, et al: Peginterferon Alfa-2a HBeAg-Negative Chronic Hepatitis B
Study Group: Peginterferon alfa-2a alone, lamivudine alone, and the
two in combination in patients with HBeAg-negative chronic
hepatitis B. N Engl J Med. 351:1206–1217. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Ramezani A, Banifazl M, Mamishi S, Sofian
M, Eslamifar A and Aghakhani A: The influence of human leukocyte
antigen and IL-10 gene polymorphisms on hepatitis B virus outcome.
Hepat Mon. 12:320–325. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sun C, Fu B, Gao Y, Liao X, Sun R, Tian Z
and Wei H: TGF-β1 down-regulation of NKG2D/DAP10 and 2B4/SAP
expression on human NK cells contributes to HBV persistence. PLoS
Pathog. 8:e10025942012. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Panjaworayan N, Payungporn S, Poovorawan Y
and Brown CM: Identification of an effective siRNA target site and
functional regulatory elements, within the hepatitis B virus
posttranscriptional regulatory element. Virol J. 7:2162010.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Mao R, Nie H, Cai D, Zhang J, Liu H, Yan
R, Cuconati A, Block TM, Guo JT and Guo H: Inhibition of hepatitis
B virus replication by the host zinc finger antiviral protein. PLoS
Pathog. 9:e10034942013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Krebs K, Böttinger N, Huang LR,
Chmielewski M, Arzberger S, Gasteiger G, Jäger C, Schmitt E, Bohne
F, Aichler M, et al: T cells expressing a chimeric antigen receptor
that binds hepatitis B virus envelope proteins control virus
replication in mice. Gastroenterology. 145:456–465. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Ding S and Robek MD: Cytidine deamination
and cccDNA degradation: A new approach for curing HBV? Hepatology.
60:2118–2121. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Soler MC, Molina JL, Díaz HA, Pinto VC,
Barrios YL, He K, Roller M and Weinstein-Oppenheimer CR: Effect of
the standardized Cimicifuga foetida extract on Hsp 27
expression in the MCF-7 cell line. Biol Res. 44:243–249. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chang JJ and Lewin SR: Immunopathogenesis
of hepatitis B virus infection. Immunol Cell Biol. 85:16–23. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Park SO, Kumar M and Gupta S: TGF-β and
iron differently alter HBV replication in human hepatocytes through
TGF-β/BMP signaling and cellular microRNA expression. PLoS One.
7:e392762012. View Article : Google Scholar : PubMed/NCBI
|
